Community Health price target lowered to $2.75 from $3.50 at Truist

Truist lowered the firm’s price target on Community Health to $2.75 from $3.50 and keeps a Hold rating on the shares after its Q3 results. Solid volume trends are driving roughly in-line revenue and adj. EBITDA vs. consensus, even though the company’s FY23 guidance was lowered, the analyst tells investors in a research note. Contract labor utilization/rates showed improvement while medical specialist fees remain challenging, the firm added.